Company Filing History:
2 out of 8 
1 out of 278 Years Active: 2007-2018
Title: Innovations of Ming-Hong Tai
Introduction
Ming-Hong Tai is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pain treatment and pharmaceutical compositions. With a total of three patents to his name, his work reflects a commitment to advancing medical science.
Latest Patents
Ming-Hong Tai's latest patents include a method for treating pain and a method for screening pharmaceutical compositions that have an anti-pain effect. The first patent involves administering an effective amount of a nucleic acid containing a PTEN nucleotide sequence to treat pain in subjects. The second patent focuses on screening pharmaceutical compositions that can stimulate the upregulation of PTEN, which is crucial for pain management. Additionally, he has developed ST104P, an anti-angiogenic agent, which is designed to treat non-tumor conditions associated with angiogenesis by administering a specific cyclic compound.
Career Highlights
Throughout his career, Ming-Hong Tai has worked with prominent organizations such as Sagittarius Life Science Corporation and National Sun Yat-sen University of Kaohsiung. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research.
Collaborations
Some of his notable coworkers include Su-Ying Liu and Zhi-Hong Wen. Their collaborative efforts have contributed to the advancement of research in pain treatment and pharmaceutical innovations.
Conclusion
Ming-Hong Tai's contributions to the field of medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in pain management and pharmaceutical development.